Evidence map›Paper›PMID 12574506›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.

Francesco Trapasso, Agnieszka Krakowiak, Rossano Cesari, Jeffrey Arkles, Sai Yendamuri, Hideshi Ishii, Andrea Vecchione, Tamotsu Kuroki, Pawel Bieganowski, Helen C Pace and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Integrated analysis ofCell cycle (Georgetown, Tex.) · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Fungicidal Activity of Recombinant Javanicin againstMolecules (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Hits, Fhits and Nits: beyond enzymatic function.Advances in enzyme regulation · 2011
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Francesco TrapassoGenetics and Molecular Biology Program, Kimmel Cancer Center, Philadelphia, PA 19107, USA.
Agnieszka Krakowiak
Rossano Cesari
Jeffrey Arkles
Sai Yendamuri
Hideshi Ishii
Andrea Vecchione
Tamotsu Kuroki
Pawel Bieganowski
Helen C Pace
Kay Huebner
Carlo M Croce
Charles Brenner
Sidney Kimmel Cancer Center · USJohns Hopkins University · US

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESISP01CA077738 · NCI · THOMAS JEFFERSON UNIVERSITY · PI HUEBNER, KAY · 2000 to 2004
$5.6M
Mechanism of Dnmt1 Up-regulation by Fhit LossR01CA075954 · NCI · UNIVERSITY OF IOWA · PI BRENNER, CHARLES M · 1997 to 2012
$3.0M
NCI NIH HHS CA56036NCI NIH HHS CA75954NCI NIH HHS CA77738NCI NIH HHS P01 CA077738NCI NIH HHS P30 CA056036NCI NIH HHS R01 CA075954
6 · The paper itself

Abstract

The FHIT gene is inactivated early in the development of many human tumors, and Fhit-deficient mice have increased cancer incidence. Viral reexpression of Fhit kills Fhit-deficient cells by induction of apoptosis. Fhit, a member of branch 2 of the histidine-triad superfamily of nucleoside monophosphate hydrolases and transferases, is a diadenosine polyphosphate hydrolase, the active-site histidine of which is not required for tumor suppression. To provide a rigorous test of the hypothesis that Fhit function depends on forming a complex with substrates, we designed a series of alleles of Fhit intended to reduce substrate-binding andor hydrolytic rates, characterized these mutants biochemically, and then performed quantitative cell-death assays on cancer cells virally infected with each allele. The allele series covered defects as great as 100,000-fold in k(cat) and increases as large as 30-fold in K(M). Nonetheless, when mutant FHIT genes were expressed in two human cancer cell lines containing FHIT deletions, reductions in apoptotic activity correlated exclusively with K(M). Mutants with 2- and 7-fold increases in K(M) significantly reduced apoptotic indices, whereas the mutant with a 30-fold increase in K(M) retained little cellular function. These data indicate that the proapoptotic function of Fhit is limited by substrate binding and is unrelated to substrate hydrolysis.

Indexed as

Acid Anhydride HydrolasesAllelesApoptosisBis(5'-adenosyl)triphosphataseCell LineFlow CytometryHumansKineticsMutationNeoplasm ProteinsNeoplasmsSubstrate SpecificityTumor Cells, CulturedAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphataseNeoplasm Proteins

Identifiers

PMID12574506
PMCPMC149877
OpenAlexW2128941900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.